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Pemphigus vulgaris (PV) is a potentially devastating 
autoimmune bullous disease that affects the mucosa 
and skin. It is characteristically associated with intra-
epidermal blistering and cell–cell dissociation due to the 
presence of autoantibodies targeting desmoglein (dsg) 
3 and dsg 1, i.e. transmembrane adhesion molecules of 
the desmosomal cadherin protein family (1–3). In most 
patients, PV characteristically starts with and affects the 
oral mucosa, although involvement of other mucosae may 
also occur (4–10). We have recently observed 2 patients, 
in whom the first clinical manifestation of PV consisted 
of chronic painful penile erosions, which represented a 
diagnostic challenge.
CASE REPORTS
Case 1. A 59-year-old man presented with painful penile erosions 
of 3-months duration. Microbiological cultures and serology for 
Treponema pallidum were negative. Under treatment with local 
antibiotics and disinfectants the erosive lesions further progressed 
and affected the entire glans penis and part of the shaft. Only after 
the patient developed painful aphthoid lesions in the oral mucosa, 
was a biopsy specimen from the oral mucosa obtained, which 
showed suprabasal blistering with acantholysis. Direct immu-
nofluorescence studies of perilesional oral mucosa demonstrated 
intercellular epithelial deposits of immunoglobulin G (IgG) and 
complement (C3). Enzyme-linked immunoassay-desmoglein 3 
(ELISA-dsg 3) (136 U/ml, normal < 7) and ELISA-dsg 1 (62 U/
ml, normal < 14) were both positive. The patient was first given 
prednisone 0.5 mg/kg body weight. However, under this regimen 
he further developed multiple vesicles and bullae on the neck, 
trunk and extremities. Prednisone was hence increased to 1 mg/
kg body weight/day and associated with azathioprine 2.5 mg/
kg/day. Genital lesions were concomitantly treated with topical 
betamethasone associated with topical antibiotics and disinfec-
tants. Thereafter, both mucous and cutaneous lesions started 
healing. Four weeks later, at the end of the consolidation phase, 
prednisone was tapered gradually. After 12 months, the patient 
remained in complete remission under therapy (Fig. 1).
Case 2. A 35-year-old man was referred for evaluation of a 
3-month history of painful penile erosions. Topical treatments 
with disinfectants and topical antibiotics had no effect. Two 
months after appearance of the genital lesions the patient also 
developed painful oral lesions. On examination, the patient had 
multiple erythematous erosions on the glans penis and sulcus 
coronarius (Fig. 2). In the oral cavity, the patient exhibited 
asymptomatic erosions in the region of the palatal arch and the 
lower lip. Histology from the glans penis showed an intraepider-
mal bulla with acantholytic cells. Direct immunofluorescence 
microscopy studies demonstrated deposits of IgG and C3 on the 
cytoplasmic membrane of the keratinocytes. ELISA-dsg 3 was 
strongly positive (146 U/ml, normal <7), whereas ELISA-dsg 
1 was negative. The patient was treated with prednisone 1 mg/
kg body weight and azathioprine 150 mg/day. Furthermore, he 
received topical betamethasone in combination with topical 
antibiotics and disinfectants. Under this regimen, the lesions 
slowly healed within 4 weeks. Prednisone dosage was subse-
quently reduced over a time period of 6 months to a daily dose 
of 7.5 mg without further exacerbation of the disease.
DISCUSSION
We present here the observation of 2 patients in which 
penile erosions represented the first and leading ma-
nifestation of PV. Although mucosal involvement in 
PV is common, it is the oral mucosa that is most fre-
quently affected, while other mucosae are significantly 
less frequently involved (3). In a retrospective series 
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Fig. 1. (A) Penile pemphigus. On initial evaluation, there were widespread 
erosions of the glans penis and of the corona glandis with denuded areas. 
The epithelium was whitish, macerated, and could be displaced easily using a 
cotton tip (Nikolsky sign). (B) Resolution of the lesions following treatment 
with prednisone and azathioprine.
Fig. 2. (A) Penile pemphigus. Isolated irregular erosions with denuded 
epithelium. At the periphery of the erosions, such as on the middle portion 
of the glans, the epithelium detaches and can be easily displaced. Note the 
stellate-like and fissured appearance reminiscent of Hailey-Hailey disease. 
(B) Resolution of the erosions under systemic therapy.
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the oral cavity, conjunctiva, nasal, vaginal, laryngeal/
oesophageal and perianal mucosae in 81%, 16%, 11%, 
9%, 8% and 2% of cases, respectively. Genital tract 
lesions have also been described in PV, but almost 
invariably in women. Akhyani et al. (12) observed ge-
nital involvement in 51%, almost invariably showing 
extensive mucocutaneous involvement. After the oral 
mucosa, genital mucosa might thus represent the second 
most commonly affected mucosal site in PV, and its 
involvement is surely under-diagnosed (12). Finally, 
the presence of genital lesions was associated with 
treatment-resistance and regarded as a poor prognostic 
factor and marker of disease severity (9). 
Although the presence of genital lesions of PV in 
men has been described anecdotally (10, 13, 14), the 
possibility of penile involvement as a first manifesta-
tion of PV has received little attention so far. The only 
report emphasizing genital involvement in men is that 
of Sami & Ahmed (13), who described 12 PV patients 
with penile lesions. Ten of these patients also had typical 
cutaneous lesions, whereas 2 had lesions involving both 
the oral and genital mucosae. The glans penis was the 
most commonly affected area, followed by the shaft 
and corona glandis. All patients responded to systemic 
corticosteroids and immunosuppressive agents, as well 
as, in some cases, to intravenous immunoglobulins, with 
no further recurrence of penile lesions. 
The clinical features of PV in the 2 cases described 
here seem to be characteristic for penile PV. Coalescing 
erosions of the glans penis and sulcus coronarius were 
present. The penile skin had a whitish macerated appea-
rance with delicate fissures. Proper diagnosis was difficult 
and delayed in both cases. Since erosive penile lesions 
are most frequently related to an infectious aetiology, 
both patients first underwent systemic topical antiviral 
and antibiotic treatments, with no effect. In one of our 
cases the initial diagnosis was that of bipolar aphthosis 
(oral and genital), and the patient was treated accordingly 
with no response. 
Sirois et al. (15) reported that patients with PV exhibi-
ting oral lesions as a first manifestation had a mean diag-
nostic delay of > 6 months. Penile involvement needs to 
be systematically excluded by clinical examination, even 
in patients without local discomfort or other symptoms.
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